SA Narod

2.0k total citations
18 papers, 1.0k citations indexed

About

SA Narod is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, SA Narod has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 8 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in SA Narod's work include BRCA gene mutations in cancer (15 papers), DNA Repair Mechanisms (5 papers) and Cancer Genomics and Diagnostics (5 papers). SA Narod is often cited by papers focused on BRCA gene mutations in cancer (15 papers), DNA Repair Mechanisms (5 papers) and Cancer Genomics and Diagnostics (5 papers). SA Narod collaborates with scholars based in Canada, United States and Poland. SA Narod's co-authors include Alexander Liede, William D. Foulkes, Jan Lubiński, Cezary Cybulski, Paul E. Goss, Nancy Hamel, Diane Allingham‐Hawkins, Corinne Serruya, Lisa Di Prospero and John Blondal and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Breast Cancer Research and Treatment.

In The Last Decade

SA Narod

18 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
SA Narod Canada	13	800	331	282	220	215	18	1.0k
Aletta Poll Canada	18	850 1.1×	430 1.3×	289 1.0×	207 0.9×	268 1.2×	29	1.1k
M Llacuachaqui Canada	14	638 0.8×	334 1.0×	277 1.0×	193 0.9×	293 1.4×	20	886
Kerstin Rhiem Germany	15	572 0.7×	258 0.8×	312 1.1×	175 0.8×	184 0.9×	28	786
J. E. Garber United States	9	549 0.7×	127 0.4×	250 0.9×	151 0.7×	268 1.2×	26	783
DF Easton United Kingdom	7	724 0.9×	318 1.0×	291 1.0×	283 1.3×	238 1.1×	16	940
Bert van Geel Netherlands	7	756 0.9×	160 0.5×	358 1.3×	199 0.9×	254 1.2×	7	896
O. Olopade United States	3	453 0.6×	148 0.4×	315 1.1×	127 0.6×	179 0.8×	4	693
Susan Randall Armel Canada	21	963 1.2×	331 1.0×	352 1.2×	251 1.1×	536 2.5×	51	1.5k
Monica Barile Italy	16	427 0.5×	359 1.1×	184 0.7×	121 0.6×	219 1.0×	26	794
M. Daly United States	6	644 0.8×	184 0.6×	189 0.7×	168 0.8×	204 0.9×	7	802

Countries citing papers authored by SA Narod

Since Specialization

Citations

This map shows the geographic impact of SA Narod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SA Narod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SA Narod more than expected).

Fields of papers citing papers by SA Narod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SA Narod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SA Narod. The network helps show where SA Narod may publish in the future.

Co-authorship network of co-authors of SA Narod

This figure shows the co-authorship network connecting the top 25 collaborators of SA Narod. A scholar is included among the top collaborators of SA Narod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SA Narod. SA Narod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Villarreal‐Garza, Cynthia, Jeffrey N. Weitzel, M Llacuachaqui, et al.. (2015). The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. Breast Cancer Research and Treatment. 150(2). 389–394. 60 indexed citations

Ghadirian, P, A. Robidoux, Edgard Nassif, et al.. (2013). Screening for BRCA1 and BRCA2 mutations among French‐Canadian breast cancer cases attending an outpatient clinic in Montreal. Clinical Genetics. 85(1). 31–35. 12 indexed citations

Singer, Christian F., Daniela Muhr, Christine Rappaport, et al.. (2013). Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria. Clinical Genetics. 85(1). 72–75. 6 indexed citations

Byrski, Tomasz, Jacek Gronwald, Tomasz Huzarski, et al.. (2012). Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment. Hereditary Cancer in Clinical Practice. 10(Suppl 3). A3–A3. 4 indexed citations

Llacuachaqui, M, et al.. (2011). BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica. Clinical Genetics. 82(5). 484–488. 24 indexed citations

Lubiński, Jan, Katarzyna Jaworska, Katarzyna Durda, et al.. (2011). Selenium and the risk of cancer in BRCA1 carriers. Hereditary Cancer in Clinical Practice. 9(Suppl 2). A5–A5. 10 indexed citations

Narod, SA. (2011). Earlier Age of Onset in BRCA Carriers—Anticipation or Cohort Effect?. Current Oncology. 18(6). 257–258. 7 indexed citations

Oszurek, Oleg, Jan Lubiński, Cezary Cybulski, et al.. (2010). The contribution of founder mutations in BRCA1 to breast cancer in Belarus. Clinical Genetics. 78(4). 377–380. 20 indexed citations

Narod, SA. (2010). Testing for CHEK2 in the cancer genetics clinic: ready for prime time?. Clinical Genetics. 78(1). 1–7. 41 indexed citations

10.

Ghadirian, P, A. Robidoux, Ping Zhang, et al.. (2009). The contribution of founder mutations to early‐onset breast cancer in French‐Canadian women. Clinical Genetics. 76(5). 421–426. 27 indexed citations

11.

Cybulski, Cezary, Tomasz Huzarski, Tomasz Byrski, et al.. (2008). Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemoprevention. Clinical Genetics. 75(1). 72–78. 45 indexed citations

12.

Metcalfe, Kelly, Aletta Poll, Annette M. O’Connor, et al.. (2007). Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 72(3). 208–217. 55 indexed citations

13.

Cybulski, Cezary, Bohdan Górski, Tadeusz Dębniak, et al.. (2004). NBS1 Is a Prostate Cancer Susceptibility Gene. Cancer Research. 64(4). 1215–1219. 111 indexed citations

14.

Metcalfe, Kelly, Alexander Liede, Martina Trinkaus, Danielle Hanna, & SA Narod. (2002). Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clinical Genetics. 62(6). 464–469. 28 indexed citations

15.

Narod, SA. (2002). Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. JNCI Journal of the National Cancer Institute. 94(23). 1773–1779. 239 indexed citations

16.

Elit, L., Ran Goshen, Helena Jernström, et al.. (2002). Familial and hormonal risk factors for papillary serous uterine cancer.. PubMed. 23(3). 187–90. 4 indexed citations

17.

Singh, Rashmi, Rosalind A. Eeles, Francine Durocher, et al.. (2000). High risk genes predisposing to prostate cancer development—do they exist?. Prostate Cancer and Prostatic Diseases. 3(4). 241–247. 17 indexed citations

18.

Warner, Elizabeth, William D. Foulkes, Pamela J. Goodwin, et al.. (1999). Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer. JNCI Journal of the National Cancer Institute. 91(14). 1241–1247. 306 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact